{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:40:42Z","timestamp":1790286042494,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>The aim of this study was to investigate the pathologic prognostic factors such as tumor cell clusters (TCCs) in the fallopian tube lumen, myometrial invasion patterns, and positive peritoneal cytology (PPC) in women with Stage I endometrial endometrioid carcinoma (EEC). From 2009 to 2020, consecutive patients with Stage I EEC who underwent hysterectomy and bilateral salpingectomy were included. The primary outcome was the recurrence-free survival (RFS) rate, and the clinicopathological factors affecting RFS were analyzed. A total of 765 patients were enrolled. Seventeen patients (2.2%) had TCC in the fallopian tube lumen, and 58 patients showed a microcystic elongated and fragmented pattern (7.6%). PPC was found in 19 patients (2.5%). The median follow-up period was 61.0 months (range: 2.0\u2013149.7). The majority (88.6%) of patients had Stage IA EEC. The 5-year RFS and overall survival rates were 97.5% and 98.5%, respectively. In multivariate analysis for RFS, the significant prognostic factors were lymphovascular invasion (hazard ratio = 4.604; 95% CI: 1.387\u201315.288; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.013) and grade (grade 2; hazard ratio = 4.949; 95% CI: 1.035\u201323.654; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.045, and grade 3; hazard ratio = 5.469; 95% CI: 1.435\u201320.848; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.013). Other pathologic factors including TCC in the fallopian tube lumen, myometrial invasion patterns, PPC, and hormonal status had no prognostic significance. TCC in the fallopian tube lumen, myometrial invasion pattern, PPC, and estrogen and progesterone receptor positivity were not significant prognostic factors in Stage I EEC. In contrast, lymphovascular invasion and grade were significant prognostic factors.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001054","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T11:00:43Z","timestamp":1719313243000},"page":"242-248","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Prognostic Value of Tumor Cell Clusters in the Fallopian Tube Lumen in Stage I Endometrioid Carcinoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Ye Jin","family":"Yoo","sequence":"first","affiliation":[{"name":"Radiation Oncology; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Joo","family":"Kim","sequence":"additional","affiliation":[{"name":"Radiation Oncology; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Man","family":"Kim","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Rae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uiree","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Radiation Oncology; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"R1-20250421","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5468\/ogs.21116","article-title":"The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry","volume":"64","author":"Ha","year":"2021","journal-title":"Obstet Gynecol Sci"},{"key":"R2-20250421","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2016.09.033","article-title":"The nature of early-stage endometrial cancer recurrence\u2014a national cohort study","volume":"69","author":"Jeppesen","year":"2016","journal-title":"Eur J Cancer"},{"key":"R3-20250421","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2016.10.025","article-title":"Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO consensus conference risk groups: results from the FRANCOGYN study group","volume":"144","author":"Bendifallah","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R4-20250421","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post-operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"R5-20250421","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R6-20250421","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"key":"R7-20250421","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1038\/bjc.2014.237","article-title":"A clue towards improving the European society of medical oncology risk group classification in apparent early-stage endometrial cancer? Impact of lymphovascular space invasion","volume":"110","author":"Bendifallah","year":"2014","journal-title":"Br J Cancer"},{"key":"R8-20250421","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2015.35","article-title":"Just how accurate are the major risk stratification systems for early-stage endometrial cancer?","volume":"112","author":"Bendifallah","year":"2015","journal-title":"Br J Cancer"},{"key":"R9-20250421","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R10-20250421","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ijgc-2020-001929","article-title":"PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer","volume":"30","author":"van den Heerik","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"1 suppl 1","key":"R11-20250421","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/PGP.0000000000000524","article-title":"Pathologic prognostic factors in endometrial carcinoma (other than tumor type and grade)","volume":"38","author":"Singh","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20250421","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2018.05.005","article-title":"Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival","volume":"150","author":"Felix","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R13-20250421","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12957-015-0619-1","article-title":"Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R14-20250421","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2006.03.003","article-title":"Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?","volume":"103","author":"Saga","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R15-20250421","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R16-20250421","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jog.13845","article-title":"Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?","volume":"45","author":"Laokulrath","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"R17-20250421","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/PGP.0b013e31823ff422","article-title":"Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion","volume":"31","author":"Quick","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20250421","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/PGP.0000000000000819","article-title":"Associations between intraluminal tumor cell involvement in serially examined fallopian tubes and endometrial carcinoma characteristics and outcomes","volume":"41","author":"Rodriquez","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20250421","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynecol Obstet"},{"key":"R20-20250421","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2018.09.036","article-title":"MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: a systematic review of the literature","volume":"230","author":"Prodromidou","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R21-20250421","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GRF.0b013e3182185baa","article-title":"Revised FIGO staging system for endometrial cancer","volume":"54","author":"Lewin","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"R22-20250421","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jjco\/hyw063","article-title":"Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis","volume":"46","author":"Lee","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"R23-20250421","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2017.03.011","article-title":"Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer","volume":"145","author":"Scott","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R24-20250421","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/modpathol.3800342","article-title":"Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer","volume":"18","author":"Fadare","year":"2005","journal-title":"Mod Pathol"},{"key":"R25-20250421","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2017.11.027","article-title":"ER and PR expression and survival after endometrial cancer","volume":"148","author":"Smith","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R26-20250421","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R27-20250421","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","article-title":"Lymphvascular space involvement: an independent prognostic factor in endometrial cancer","volume":"96","author":"Bri\u00ebt","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R28-20250421","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2013a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"R29-20250421","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PGP.0000000000000806","article-title":"Defining substantial lymphovascular space invasion in endometrial cancer","volume":"41","author":"Peters","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R30-20250421","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:00:16Z","timestamp":1745251216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001054","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}